SMS Terms & Conditions

1. Program Description

Bond Health, Inc. (“Bond Trials”) operates an SMS messaging service on behalf of its healthcare and clinical research organization customers. Text messages sent through Bond Trials are used exclusively for clinical trial prescreening outreach - contacting prospective participants to determine their eligibility for specific research studies.

Messages may include: information about a specific clinical trial, eligibility screening questions, scheduling invitations for an in-person screening visit, and follow-up communications related to a specific study.

2. Message Frequency

Message frequency varies based on the prescreening workflow for a given clinical trial. In general, you may receive up to 4 messages per active prescreening conversation. You will not receive messages unrelated to the specific trial for which your number was provided.

3. How to Opt Out

You may opt out of SMS messages at any time by replying STOP to any message. After texting STOP, you will receive a single confirmation message and no further messages will be sent.

Other opt-out keywords that are recognized: STOP ALL, STOPALL, UNSUBSCRIBE, CANCEL, END, QUIT. All produce the same result - immediate removal from further messaging.

4. How to Get Help

For help, reply HELP or INFO to any message or contact us at support@bondtrials.com. Standard response time is 1-2 business days.

5. Message and Data Rates

Message and data rates may apply depending on your mobile carrier plan. Bond Trials does not charge for messages; however, your carrier may. Contact your carrier for details on your messaging plan.

6. Supported Carriers

This service is available on all major US wireless carriers, including AT&T, T-Mobile, Verizon, U.S. Cellular, and others. Messages are sent from a standard 10-digit local number registered for A2P 10DLC. If you are unable to receive messages, contact your carrier.

7. Privacy and Data Use

Your mobile number and opt-in consent are used solely to conduct the prescreening conversation described in Section 1. We do not share, sell, or transfer your mobile number or opt-in data to any third party for marketing or any purpose other than the clinical research messaging for which consent was obtained. For full details, see our Privacy Policy.

8. Re-subscribing

If you have previously opted out and would like to re-enable messages, reply START, YES or UNSTOP to the number that originally messaged you, or contact your clinical trial coordinator directly.

9. Changes to These Terms

Bond Trials may update these terms from time to time. Continued participation in the messaging program after changes are posted constitutes acceptance of the revised terms.

10. Contact